OIL 0.00% 4.8¢ optiscan imaging limited

phase three trials

  1. 2,502 Posts.
    lightbulb Created with Sketch. 10
    This is good news. Looks like two trials from the Barrow institute to assess 5-ALA fluorescence agent with confocal microscope in brain surgery. This would be the phase 3 confirmatory trial. The primary completion date may have already passed

    Column 1 Column 2
    0 Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)

    https://www.clinicaltrials.gov/ct2/...urgery for Low- and High-grade Gliomas&rank=1

    http://www.cancer.gov/clinicaltrials/search/view?cdrid=721822&version=Patient

    https://www.clinicaltrials.gov/ct2/...urgery for Low- and High-grade Gliomas&rank=2


    https://www.clinicaltrials.gov/ct2/...or Low- and High-grade Gliomas &Search=Search

    Whatever the traders are doing atm won`t matter with positive outcomes from these trials.
 
watchlist Created with Sketch. Add OIL (ASX) to my watchlist
(20min delay)
Last
4.8¢
Change
0.000(0.00%)
Mkt cap ! $20.76M
Open High Low Value Volume
4.8¢ 4.8¢ 4.8¢ $4.476K 93.25K

Buyers (Bids)

No. Vol. Price($)
1 49034 4.7¢
 

Sellers (Offers)

Price($) Vol. No.
4.8¢ 115517 2
View Market Depth
Last update - 13.10pm 19/03/2019 (20 minute delay) ?
(live)
Last
4.8¢
  Change
0.000 ( 0.00 %)
Open High Low Volume
4.8¢ 4.8¢ 4.8¢ 9228
Last updated 13.10pm 19/03/2019 (live) ?
OIL (ASX) Chart
GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.